| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-785 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2017-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95b6f7f13b5585ed732fde5ac2fd0a39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06edd76f224260a697febd4099587a66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab91510a2c332a059910cec9f1059aa7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_624c0bc4b1f3d3dc4c007e37704dbfe6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67011fc2587e7a261f52378e030fa828
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0014cbe9962693d11f5d58108e38be6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7f6521e44329b9a6b9e7b8f8fdb9d75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5971bb6d91ac1f11724b8bdcba41a32 |
| publicationDate |
2019-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-109922804-A |
| titleOfInvention |
Combination of FGFR4 inhibitor and bile acid sequestrant |
| abstract |
The present invention relates to a pharmaceutical combination comprising an FGFR4 inhibitor and a bile acid sequestrant, the use of said pharmaceutical combination in the treatment of cancer and the use of a bile acid sequestrant for reducing or ameliorating the side effects associated with FGFR4 inhibition therapy. |
| priorityDate |
2016-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |